Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Boehringer Ingelheim initiates phase I study of BI-1291583

Feb. 12, 2018

Insmed studies INS-1007 in phase II for non-cystic fibrosis bronchiectasis

Feb. 8, 2018

Bayer divulges novel TASK-1/3 blockers

Feb. 8, 2018

INSERM and collaborators patent stromal cell-derived factor 1 inhibitors

Feb. 8, 2018

Synairgen initiates phase II trial of inhaled SNG-001 in COPD

Feb. 7, 2018

PTGDR2 antagonists patented by Jiangsu Chia Tai Tianqing Pharmaceutical, Medshine Discovery

Feb. 5, 2018

Vertex selects VX-659 and VX-445 to advance into phase III cystic fibrosis triple combination trials

Feb. 1, 2018

Chiesi Farmaceutici discloses new compounds for asthma

Jan. 31, 2018

Corbus Pharmaceuticals receives award to support phase IIb study of lenabasum

Jan. 31, 2018

FDA accepts revefenacin NDA

Jan. 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
In monkeys, enhanced TB vaccine dissolves after inducing protection
BioWorld Science
An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...